Roberta Camisa

Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/ <i>neu</i> –Positive Metastatic Breast Cancer

Antonino Musolino, Nadia Naldi, Beatrice Bortesi et al. · Journal of Clinical Oncology · 2008 · 949 citations · Full text

First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status

Francesco Facchinetti, Giulia Mazzaschi, Fausto Barbieri et al. · European Journal of Cancer · 2020 · 145 citations · Full text

First-line Pembrolizumab, Medicine, Pathology +6

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study

Antonino Musolino, Maria Angela Bella, Beatrice Bortesi et al. · The Breast · 2007 · 130 citations

Breast Oncology, Somatic Variant, Molecular Markers +9

Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): Study of a comprehensive panel of molecular markers

Marcello Tiseo, Giulio Rossi, Marzia Capelletti et al. · Lung Cancer · 2009 · 76 citations

Prognostic Biomarkers, Gefitinib Outcomes, Molecular Markers +9

Comparison of the results of immunocytochemical assays for biologic variables on preoperative fine-needle aspirates and on surgical specimens of primary breast carcinomas

Rita Nizzoli, Cecilia Bozzetti, Nadia Naldi et al. · Cancer · 2000 · 52 citations